Zynerba Pharmaceuticals, Inc.·4

Jul 3, 3:13 PM ET

FEDERICI WILLIAM J 4

4 · Zynerba Pharmaceuticals, Inc. · Filed Jul 3, 2018

Insider Transaction Report

Form 4
Period: 2018-07-02
Transactions
  • Award

    Stock Option (right to buy)

    2018-07-02$6.24/sh+1,103$6,8771,103 total
    Exercise: $9.70From: 2018-07-02Exp: 2028-07-02Common Stock (1,103 underlying)
Footnotes (1)
  • [F1]This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $6,875.00.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT